Clinical Trial Update: Open-label, Phase I/IIa Study of VAC-3S in HIV-1 Patients Who Showed an Immune Response to VAC-3S During IVVAC-3S/P1 [Phase 1, Phase 2]

View source ↗

Summary

Open-label Phase 1/2a trial of VAC-3S in HIV-1 patients who showed an immune response to VAC-3S during an earlier IVVAC-3S/P1 study; the current status of the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VAC-3S

Snippet

Sponsor: InnaVirVax | Conditions: HIV | Phase 1, Phase 2 | Status: UNKNOWN